Top 10 Companies in Iodine-131 Market: Growth Outlook, Innovation Trends, and Forecast 2025–2031
Market Overview
Global Iodine-131 market was valued at USD 1,859.21 thousand in 2023 and is projected to reach USD 2,578.25 thousand by 2030, growing at a CAGR of 5.06% from 2024 to 2030.
North America is expected to grow from USD 653.88 thousand in 2023 to USD 891.04 thousand by 2030, with a CAGR of 4.78%.
Asia-Pacific market is projected to grow from USD 477.07 thousand in 2023 to USD 677.56 thousand by 2030, at a CAGR of 5.46%.
Iodine-131 (I-131) is a radioactive isotope extensively used in nuclear medicine, particularly in diagnosing and treating thyroid-related disorders such as hyperthyroidism and thyroid cancer. Produced in nuclear reactors, I-131 emits radiation as it decays and is known for its targeted therapeutic effects.
Top Companies in Iodine-131 Market
Jubilant DraxImage
NTP
IRE - IRE ELiT
Isotope JSC
Nordion
POLATOM
In 2023, the top three companies held approximately 61.93% of total market revenue, highlighting a consolidated market landscape.
Market Segmentation
By Type
Solution
Capsule
By Application
Medical Use
Industrial Use
Production by Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Consumption by Region
North America (U.S., Canada)
Asia-Pacific (China, Japan, South Korea, Southeast Asia, India)
Europe (Germany, France, U.K., Italy, Russia, Rest of Europe)
Latin America (Mexico, Brazil, Rest of Latin America)
Middle East & Africa (Turkey, GCC Countries)
Market Drivers
- Rising Incidence of Thyroid Disorders
The global rise in thyroid-related illnesses is driving the demand for Iodine-131 in both diagnostic imaging and therapeutic treatments. - Advancements in Nuclear Medicine
Technological advancements like PET/CT and SPECT/CT have improved precision, increasing the adoption of I-131. - Increased Adoption of Targeted Therapy
I-131 provides targeted treatment by selectively accumulating in thyroid tissues, reducing side effects and enhancing efficacy. - Growing Geriatric Population
The aging global population, more susceptible to thyroid conditions, contributes significantly to rising demand. - Government Support and Healthcare Investments
Investments in healthcare infrastructure and supportive policies for cancer treatment further propel market expansion. - Expanding Role in Non-Thyroid Applications
New research is uncovering I-131’s potential in treating non-thyroid cancers, widening the application base.
Market Restraints
- Strict Regulatory Frameworks
Handling radioactive materials involves navigating stringent international and regional safety regulations. - Short Half-Life of Iodine-131
With a half-life of only 8 days, logistical and distribution challenges limit availability in remote regions. - High Production Costs
Sophisticated equipment and safety protocols increase production costs, affecting affordability. - Side Effects and Health Risks
Though effective, I-131 may cause nausea, fatigue, and radiation exposure risks, reducing patient preference in certain cases. - Competition from Alternative Therapies
Non-radioactive treatments like molecular and immunotherapy present competition in specific indications.
Market Opportunities
- Rising Demand in Emerging Markets
Asia-Pacific, Latin America, and Africa are witnessing growth in healthcare infrastructure and nuclear medicine facilities. - Development of Advanced Radioisotope Production Techniques
Enhanced production methods improve supply consistency and reduce operational costs. - Integration of AI in Nuclear Medicine
AI is improving diagnostic accuracy and personalizing treatment plans, boosting clinical outcomes with I-131. - Expansion into Veterinary Medicine
Growing usage in veterinary oncology for conditions like feline hyperthyroidism adds a new growth avenue. - Collaborations Between Academia and Industry
Joint R&D initiatives drive innovation, leading to new formulations and expanded applications. - Focus on Sustainable Practices
Efforts toward eco-friendly production and waste management systems increase sustainability and market attractiveness.
Market Challenges
- Global Supply Chain Disruptions
Reliance on specialized production facilities makes the market vulnerable to supply shocks from geopolitical issues or natural disasters. - Lack of Infrastructure in Developing Regions
Many regions lack necessary infrastructure like radiopharmacies and nuclear reactors to utilize I-131 efficiently. - Radiation Safety Concerns
Public perception and professional safety concerns surrounding radiation use may limit adoption. - Competition from Other Isotopes
Alternatives like Lutetium-177 and Yttrium-90 are gaining attention for certain cancers, diverting market share. - Complex Licensing and Compliance Processes
Navigating global compliance standards and obtaining licenses can be time-consuming and resource-intensive, delaying market expansion.
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Email: help@intelmarketresearch.com
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports
Related URL
https://localbizinfo.net/blogs/50955/Top-10-Companies-in-Iodine-131-Market-Growth-Outlook-Innovation
https://g20social.com/blogs/1240/Top-10-Companies-in-Iodine-131-Market-Growth-Outlook-Innovation
https://www.bundas24.com/blogs/42133/Top-10-Companies-in-Iodine-131-Market-Growth-Outlook-Innovation
https://vintfint.com/blogs/64695/Top-10-Companies-in-Iodine-131-Market-Growth-Outlook-Innovation
https://animesocial.su/blogs/94610/Top-10-Companies-in-Iodine-131-Market-Growth-Outlook-Innovation
https://hasster.com/blogs/149719/Top-10-Companies-in-Iodine-131-Market-Growth-Outlook-Innovation
https://band.us/page/98571652/post/229
https://padlet.com/raniwaghmare2424/rani-m8pkhvx3w6k77c8g/wish/KxJvag9MVdbVZAg0
https://blog.naver.com/raniwaghmare/223903474172
https://hackmd.io/@PEyhhCuzQ2yXASx_6ksl3A/S1QU4RJVeg
https://www.pearltrees.com/raniwaghmare/item721023113
https://leetcode.com/discuss/post/6856428/top-10-companies-in-iodine-131-market-gr-ll51/
Comments
Post a Comment